Exscientia plc EXAI 深 滬
等待開盤 02-07 09:30:00 美东时间
4.84
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 4.84
- 總市值 6.33亿
- 52周最高 7.91
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 3.80
- 委 比 0.00%
- 總股本 1.31亿
- 歷史最高 30.38
- 量 比 0
- 振 幅 0.00%
- 歷史最低 3.80
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多晶泰科技何以“膝斩直下”
开辟多元化收入 作者：郑敏芳 编辑：松壑 上市不足半年，头顶 AI 制药第一股的QUANTUMPH-P（2228.HK，下称“晶泰科技”）股价迎来剧烈下挫并跌破...
2024-11-21 08:00
Exscientia and Recursion Merge to Revolutionize Drug Discovery
Exscientia Plc (EXAI) has released an update. Exscientia Plc merges with Recurs...
2024-11-20 22:49
Recursion and Exscientia Merger Approved by Shareholders
Exscientia Plc (EXAI) has released an update. Shareholders of Recursion and Exs...
2024-11-13 23:59
Exscientia Plc Gains Strong Shareholder Support
Exscientia Plc (EXAI) has released an update. Exscientia Plc announced that its...
2024-11-13 06:24
Exscientia Plc Faces Financial Challenges Amid Rising Costs
Exscientia Plc (EXAI) has released an update. Exscientia Plc has released its u...
2024-11-08 19:58
Exscientia to receive $15M in milestones for Sanofi collaboration
Exscientia plc (NASDAQ:EXAI) announced the advancement of two additional discovery programmes within its collaboration with Sanofi, with Exscientia receiving an aggregate of $15M in milestone payments...
2024-10-16 20:39
Recursion, Exscientia seek support for merger ahead of special meeting
AI-focused drug discovery firms Recursion (NASDAQ:RXRX) and Exscientia (NASDAQ:EXAI) on Thursday solicited shareholder support for their proposed merger agreement at upcoming investor meetings next mo...
2024-10-10 20:26
Exscientia reports Q2 results
Exscientia press release (NASDAQ:EXAI): Q2 GAAP EPS of -$0.36. Revenue of $5.6M (+47.4% Y/Y). More on Exscientia Recursion's Acquisition Of Exscientia Makes Sense On Some Levels, Not Others Exscientia...
2024-08-16 13:57
Exscientia’s Strategic Merger and Pipeline Progress
Exscientia Plc (EXAI) has released an update. Exscientia Plc is set to revoluti...
2024-08-15 19:47
